Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

NCT02758951 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

358

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasm
Colorectal Cancer
Colorectal Neoplasms Malignant
Colorectal Carcinoma
Colorectal Adenocarcinoma
Peritoneal Neoplasms
Peritoneal Carcinomatosis
Peritoneal Cancer
Peritoneal Metastases
Peritoneal Neoplasm Malignant Secondary Carcinomatosis
Peritoneal Neoplasm Malignant Secondary

Interventions

OTHER: Perioperative systemic therapy
COMBINATION_PRODUCT: Perioperative CAPOX-bevacizumab
COMBINATION_PRODUCT: Perioperative FOLFOX-bevacizumab
COMBINATION_PRODUCT: Perioperative FOLFIRI-bevacizumab
PROCEDURE: CRS-HIPEC, experimental arm
PROCEDURE: CRS-HIPEC, control arm

Sponsor

Koen Rovers

Collaborators

[object Object]
[object Object]
[object Object]